Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics

Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics


  • Products Id :- GBI081CBR
  • |
  • Pages: 78
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics

Summary

Although the pharmaceutical market is continuing to witness global growth, pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market, such as increasing costs of production and R&D, shifts in patent laws, and challenges in the economy. Companies are considering various strategies to overcome these challenges, with deal making being foremost among these as a means of boosting revenues over a short period of time.

Small companies that primarily carry out early-stage research, development and production activities are entering into agreements with key industry leaders to out-license the rights to their products, utilizing the strengths of the larger companies in terms of commercialization expertise, manufacturing, distribution and marketing capabilities and global presence. Additionally, many companies have successfully implemented deal-making strategies to secure extended protection for their products from generic competitors. Deal activity can help pharma companies to enhance their research and regulatory approaches, and can aid portfolio expansion and diversification, geographic expansion, entry into niche markets, commercialization, and sales.

This report analyzes the importance of deal making in the pharmaceutical and healthcare market. It covers key factors that encourage deal activity in the pharmaceutical industry, and the key strategies being implemented when companies strike deals. An overview of recent deal activity from 2010 to May 2017 is also included.

Scope

What deal making strategies have been used in recent years to boost R&D productivity and allow the successful commercialization of pharmaceutical products?

In which geographical markets and disease areas has deal activity been focused since 2010?

At which stage of development did deals most frequently occur, and attract the highest value?

How have pharma companies been using deal making to strengthen their product portfolio and bottom line?

What are the most significant Mergers and Acquisitions (M&As), licensing deals and partnership deals to have been announced since 2016?

Who are the major players in pharmaceutical deal making, and what has been their recent and key deal activity?

Key Reasons to Purchase

Gain a comprehensive understanding of the most recent healthcare deal trends.

Understand the most significant M&As, licensing deals and partnerships to have occurred in recent years.

Comprehensively analyze the trends of deal activity from 2010 to May 2017, with respect to aggregate deal value, geography, and the therapy area and stage of development of the products involved.

Understand the deal-making strategies that have been historically implemented by companies, and identify the most suitable strategies for boosting R&D portfolio and bottom line performance.

Identify the key deal terminations that have occurred in recent years, and understand their effect.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Introduction

Overview

Factors Promoting Deal Activity

Key Strategies Implemented in Deals

Geographical Expansion

Portfolio Enhancement

Market Consolidation

Improving Research and Development

Product Lifecycle management

Entry into Rare disease Markets

Deal Types

Mergers and Acquisitions (M&As)

Overview

Key Announced Deals in M&As

Terminated M&As

Asset Swaps

Key Asset Swaps

Partnerships

Overview

Key Announced Deals

Terminated Partnerships

Licensing

Overview

Key Announced Deals

Terminated Licensing deals

Overview of Pharmaceutical Deals from 2010 to 2016

Pharmaceutical Deals by Value and Year

Number of Deals by Region/Country

Number of Deals by Prominent Therapy Area

Number of Deals by Stage of Development

Number of Deals by Molecule Type

Number of deals and Value by Type of Deal

Key Players

Conclusions and Future Scope

Bibliography

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

select a license

Single User License
USD 2995 INR 192728
Site License
USD 5990 INR 385457
Corporate User License
USD 8985 INR 578185

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com